4th Digital Therapeutics
and Pharma Summit
Event is Over
Stay Updated for 2025 edition
Past Speakers
SEE THE PREVIOUS SPEAKERS & CASE STUDIES
Fatima Bennai-Sanfourche
Sr. Director of QA & RA Compliance for Medical devices, Combination products, and eHealth
CASE STUDY
Navigating Opportunities and Challenges of Using Digital Tools Medical Devices in Drug Clinical Trials
Patient-centric approaches are required to ensure that patients have a single source of information for all their treatments and the related expert-curated medical information. Platforms can enable these patient-centric solutions while also offering opportunities for Pharmaceutical and digital health entrepreneurs to bring solutions to patients without major development effort.
The presentation will give an overview of the main topics and challenges of supply chain and logistics in an environment with dangerous chemicals and quality-sensitive products. You will get insights regarding a make-or-buy decision for storage and distribution and several other best practices. With regard to the actual “world of transformation”, there will also be interesting thoughts about deployment & transformation — especially how to find the right factors in scaling the final positioning of a so-called minimum viable product.
- 01Which digital tools or medical devices are currently used in drug clinical trials?
- 02How are they collectively improving the efficiency, accuracy, and patient-centricity of clinical trials?
- 03How do you address regulatory and compliance challenges?
- 04What are the challenges for the sponsor and the health institutions in using these tools?
- 05Can these digital tools reduce Costs and enhance the Efficiency of conducting and executing the studies?
CASE STUDY
Don’t Tell My Doctor, but My Phone Thinks I Need a Checkup: AI Gets Personal
Imagine a healthcare experience tailored just for you—where your medical needs, preferences, and lifestyle are all considered to provide the most effective care. This isn’t a scene from a sci-fi movie; it’s the emerging reality thanks to artificial intelligence.
By integrating AI into various facets of patient engagement, pharmaceutical companies are personalising the healthcare experience like never before. This transformation not only improves the effectiveness of treatments but also empowers patients to take a more active role in their health journey. As we move forward, the responsible use of AI promises a future where personalised care is the norm and each patient’s unique needs are met with precision and compassion.
- 01Empowering patient engagement: Highlight how AI personalising health information, making it more engaging and accessible, thus motivating individuals to take charge of their well-being
- 02Interactive patient engagement platforms: Explain how pharma-developed apps and platforms leverage AI to provide personalised health content, reminders, and support, enhancing the patient experience and fostering adherence to treatment plans
- 03Virtual assistants and chatbots: Describe the implementation of AI-powered chatbots by pharma firms to offer 24/7 personalised patient support, answer medication-related questions, and provide real-time assistance, improving accessibility and satisfaction
Lenin Chaturvedi
Senior Vice President of Data, Digital & Technology, Plasma-Derived Therapies
CASE STUDY
Harnessing the Power of Digital Technologies to Transform the Journey of Potentially Life-Saving Therapies
Plasma-derived therapies (PDTs) are life-changing and life-sustaining medicines that people with rare and complex chronic diseases around the world rely on every day. Plasma is a scarce resource that cannot be made artificially, and hundreds of plasma donations – and sometimes over a thousand – are needed to make enough therapy for just one patient for one year. This is a complex, large-scale business in which growth in demand for therapies is outpacing supply – and patients’ lives are at stake. At Takeda, our priority is to ensure a sustained supply of PDTs for the patients worldwide who depend on them. This presentation will share more on how we harness data, digital, and technology (DD&T) to make every step of our end-to-end process better, faster, and more efficient – from using AI to advance operational efficiencies to developing novel device and digital solutions for patients.
- 01Improving the donation experience
- 02Improving manufacturing
- 03Improving the patient experience
CASE STUDY
7 Things to Avoid When Planning a Successful DTx Commercialisation
During the past 1.5 years, we have learned a lot about operating a DiGA start-up x Pharma collaboration. Even if we haven’t yet reached the success we aspired to, we did learn a lot along the way. We invite you to join our session so you can avoid the mistakes we have made.
In this session, we delve into the transformative world of omnichannel communication within global and local medical affairs. We will explore strategies and requirements for implementing an omnichannel approach, ensuring healthcare professionals have seamless access to diverse resources across multiple platforms. The session will highlight how leveraging data can refine and personalise communication methods, thus enhancing their impact on the target audience. Additionally, the presentation will address the importance of facilitating effective cross-functional communication among medical and commercial teams, especially in fostering a unified strategy. Finally, we will explore methods to tailor content and messaging to suit the diverse preferences of different healthcare professionals and stakeholders. This session promises to offer valuable insights and practical tools for anyone looking to enhance their communication strategies in the rapidly evolving healthcare sector.
- 01Market overview
- 02Seven things to avoid
- 03Promoting your DTx digitally only
- 04Using the same FF approach as for Rx
- 05Choosing the wrong partners (study, strategy,…)
Amelie Fassbender
Regional Medical Director – Business Development and Digital Therapeutics Lead
CASE STUDY
Patient-Centric Approaches and Social Impact
Emphasising the importance of user-centred design principles to create engaging, effective, and accessible DTx solutions for patients with varying needs and abilities.
Welcome to “Charting the Course: Our Influence on the HCP/Customer Engagement Trek”. Today, we embark on a journey to explore our impact on the ever-evolving landscape of healthcare professional (HCP) and customer engagement. In a world shaped by technology, ethics, and personalisation, our role as navigators of this journey is pivotal. Throughout this discourse, we’ll delve into key topics that define our approach, from leveraging technology to building meaningful connections. Join me as we navigate through these waters together, shaping not just outcomes, but the very fabric of trust and collaboration that underpins every meaningful engagement.
- 01Promoting health equity and access in DTx: Overcoming social and economic hurdles in DTx adoption
- 02Digital literacy and DTx education for patients: Strategies for empowering patients with the knowledge and skills needed to utilise DTx solutions effectively
- 03The role of patient advocacy groups in DTx development
- 04DTx for mental health & bridging the gap between need and access: Exploring how DTx can help address the growing mental health crisis by offering scalable and accessible solutions to improve mental well-being
Fatima Bennai-Sanfourche
Sr. Director of QA & RA Compliance for Medical devices, Combination products, and eHealth
CASE STUDY
Navigating Opportunities and Challenges of Using Digital Tools Medical Devices in Drug Clinical Trials
Patient-centric approaches are required to ensure that patients have a single source of information for all their treatments and the related expert-curated medical information. Platforms can enable these patient-centric solutions while also offering opportunities for Pharmaceutical and digital health entrepreneurs to bring solutions to patients without major development effort.
The presentation will give an overview of the main topics and challenges of supply chain and logistics in an environment with dangerous chemicals and quality-sensitive products. You will get insights regarding a make-or-buy decision for storage and distribution and several other best practices. With regard to the actual “world of transformation”, there will also be interesting thoughts about deployment & transformation — especially how to find the right factors in scaling the final positioning of a so-called minimum viable product.
- 01Which digital tools or medical devices are currently used in drug clinical trials?
- 02How are they collectively improving the efficiency, accuracy, and patient-centricity of clinical trials?
- 03How do you address regulatory and compliance challenges?
- 04What are the challenges for the sponsor and the health institutions in using these tools?
- 05Can these digital tools reduce Costs and enhance the Efficiency of conducting and executing the studies?
CASE STUDY
Don’t Tell My Doctor, but My Phone Thinks I Need a Checkup: AI Gets Personal
Imagine a healthcare experience tailored just for you—where your medical needs, preferences, and lifestyle are all considered to provide the most effective care. This isn’t a scene from a sci-fi movie; it’s the emerging reality thanks to artificial intelligence.
By integrating AI into various facets of patient engagement, pharmaceutical companies are personalising the healthcare experience like never before. This transformation not only improves the effectiveness of treatments but also empowers patients to take a more active role in their health journey. As we move forward, the responsible use of AI promises a future where personalised care is the norm and each patient’s unique needs are met with precision and compassion.
- 01Empowering patient engagement: Highlight how AI personalising health information, making it more engaging and accessible, thus motivating individuals to take charge of their well-being
- 02Interactive patient engagement platforms: Explain how pharma-developed apps and platforms leverage AI to provide personalised health content, reminders, and support, enhancing the patient experience and fostering adherence to treatment plans
- 03Virtual assistants and chatbots: Describe the implementation of AI-powered chatbots by pharma firms to offer 24/7 personalised patient support, answer medication-related questions, and provide real-time assistance, improving accessibility and satisfaction
Lenin Chaturvedi
Senior Vice President of Data, Digital & Technology, Plasma-Derived Therapies
CASE STUDY
Harnessing the Power of Digital Technologies to Transform the Journey of Potentially Life-Saving Therapies
Plasma-derived therapies (PDTs) are life-changing and life-sustaining medicines that people with rare and complex chronic diseases around the world rely on every day. Plasma is a scarce resource that cannot be made artificially, and hundreds of plasma donations – and sometimes over a thousand – are needed to make enough therapy for just one patient for one year. This is a complex, large-scale business in which growth in demand for therapies is outpacing supply – and patients’ lives are at stake. At Takeda, our priority is to ensure a sustained supply of PDTs for the patients worldwide who depend on them. This presentation will share more on how we harness data, digital, and technology (DD&T) to make every step of our end-to-end process better, faster, and more efficient – from using AI to advance operational efficiencies to developing novel device and digital solutions for patients.
- 01Improving the donation experience
- 02Improving manufacturing
- 03Improving the patient experience
CASE STUDY
7 Things to Avoid When Planning a Successful DTx Commercialisation
During the past 1.5 years, we have learned a lot about operating a DiGA start-up x Pharma collaboration. Even if we haven’t yet reached the success we aspired to, we did learn a lot along the way. We invite you to join our session so you can avoid the mistakes we have made.
In this session, we delve into the transformative world of omnichannel communication within global and local medical affairs. We will explore strategies and requirements for implementing an omnichannel approach, ensuring healthcare professionals have seamless access to diverse resources across multiple platforms. The session will highlight how leveraging data can refine and personalise communication methods, thus enhancing their impact on the target audience. Additionally, the presentation will address the importance of facilitating effective cross-functional communication among medical and commercial teams, especially in fostering a unified strategy. Finally, we will explore methods to tailor content and messaging to suit the diverse preferences of different healthcare professionals and stakeholders. This session promises to offer valuable insights and practical tools for anyone looking to enhance their communication strategies in the rapidly evolving healthcare sector.
- 01Market overview
- 02Seven things to avoid
- 03Promoting your DTx digitally only
- 04Using the same FF approach as for Rx
- 05Choosing the wrong partners (study, strategy,…)
Amelie Fassbender
Regional Medical Director – Business Development and Digital Therapeutics Lead
CASE STUDY
Patient-Centric Approaches and Social Impact
Emphasising the importance of user-centred design principles to create engaging, effective, and accessible DTx solutions for patients with varying needs and abilities.
Welcome to “Charting the Course: Our Influence on the HCP/Customer Engagement Trek”. Today, we embark on a journey to explore our impact on the ever-evolving landscape of healthcare professional (HCP) and customer engagement. In a world shaped by technology, ethics, and personalisation, our role as navigators of this journey is pivotal. Throughout this discourse, we’ll delve into key topics that define our approach, from leveraging technology to building meaningful connections. Join me as we navigate through these waters together, shaping not just outcomes, but the very fabric of trust and collaboration that underpins every meaningful engagement.
- 01Promoting health equity and access in DTx: Overcoming social and economic hurdles in DTx adoption
- 02Digital literacy and DTx education for patients: Strategies for empowering patients with the knowledge and skills needed to utilise DTx solutions effectively
- 03The role of patient advocacy groups in DTx development
- 04DTx for mental health & bridging the gap between need and access: Exploring how DTx can help address the growing mental health crisis by offering scalable and accessible solutions to improve mental well-being
Ahmed Nasr
Operations Director Egypt and Director Milk Africa & Turkey
Khaled Elsharkawy
Integrated Supply Chain Senior Director
Mueen Uddin Siddique
Senior Director – Access Network Procurement
Shannon Hore
Senior Vice President Procurement and Logistics
Sandeep Sharma
Director Group Procurement & International Markets Supply Chain
Hottest topics
LOOK AT THE TOPICS THAT WERE DISCUSSED
- 01Upcoming Novelties & AI/ML Integration
- 02Current Situation: The Rise of DTx
- 03Nowadays Challenges & What Needs Improvement
- 04Collaborations: Building a Stronger Future
- 05Policy and Regulatory Considerations
- 06Patient-Centric Approaches and Social Impact
Testimonials
What our users say about our conferences
It was a pleasure to be part of this conference. Well done to everyone involved – I have heard a lot of good insights.
Pfizer
Country Lead, Vaccines
Well organised event with professional speeches, very informative, helps to enhance knowledge and experience.
Servier
Head of International Medical Affairs
Very productive and inspiring, good networking opportunities.
Grünenthal
Senior VP Global Head of Medical Affairs,
In general it was useful and insightful. Thanks a lot!
CSL Behring
Senior Director Medical Affairs
Sponsors
Our Trusted Sponsor at This Summit
Download our App to
Enhance Your Event Experience
This innovative app is aimed at enhancing your networking experience through a seamless blend of interaction and connectivity. We have carefully crafted this application with new features that empower you to make the most out of your engagements, ensuring personalised experiences and seamless networking opportunities.
STAY UPDATED FOR THE 2025 EDITION
Provide Us With Your Contact Details and Our Team Will Get Back to You
With All the Updates Regarding the Upcoming Edition of This Event.
With All the Updates Regarding the Upcoming Edition of This Event.